Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday gave Pfizer permission to take the case to the Court of Appeal. Pfizer and BioNTech sued Moderna in September 2022, seeking to revoke Moderna's two patents. Additionally, Moderna faced criticism from a U.K. trade group for offering children $2,000 to participate in a COVID-19 trial, which was deemed to have brought discredit upon the pharmaceutical industry. The legal dispute is described as a multimillion-pound battle.
A U.K. trade group decided Moderna violated industry codes by failing to maintain high standards and bringing “discredit" upon the industry. https://t.co/vVVjbl0Djm
Multimillion-pound legal battle between rival developers of Covid-19 jabs over vaccine technology patents is set to continue at the Court of Appeal https://t.co/HUwa0aPvwT https://t.co/4DRANFLHxl
Moderna is scolded by a U.K. trade group for offering kids $2,000 to participate in a Covid trial.. https://t.co/1I3NkjBP5b #pharma #vaccines #Covid19 #clinicaltrials $MRNA